Changes for page Tandem Diabetes Care

Last modified by Asif Farooqui on 2020/01/06 07:00
From version < 1.3 >
edited by Asif Farooqui
on 2020/01/06 06:58
To version < 2.1 >
edited by Asif Farooqui
on 2020/01/06 06:59
< >
Change comment: There is no comment for this version

Summary

Details

Page properties
Content
... ... @@ -4,7 +4,7 @@
4 4  
5 5  = Overview =
6 6  
7 -Tandem Diabetes Care is a medical device company with an innovative approach to the design, development and commercialization of products for people with insulin-dependent diabetes. The company believe that its competitive advantage is rooted in its unique consumer-focused approach and proprietary technology platform. This allows it to deliver innovative hardware and software solutions to meet the various needs and preferences of people with diabetes and their healthcare providers. The company manufacture and sell insulin pump products in the United States that are designed to address large and differentiated segments of the insulin-dependent diabetes market. The company's insulin pump products include:
7 +Tandem Diabetes Care (TNDM) is a medical device company with an innovative approach to the design, development and commercialization of products for people with insulin-dependent diabetes. The company believe that its competitive advantage is rooted in its unique consumer-focused approach and proprietary technology platform. This allows it to deliver innovative hardware and software solutions to meet the various needs and preferences of people with diabetes and their healthcare providers. The company manufacture and sell insulin pump products in the United States that are designed to address large and differentiated segments of the insulin-dependent diabetes market. The company's insulin pump products include:{{footnote}}https://fintel.io/doc/sec-tndm-tandem-diabetes-care-10k-annual-report-2018-march-01-18003{{/footnote}}
8 8  
9 9  * the t:slim X2 Insulin Delivery System, or t:slim X2, its next-generation flagship product that is updatable and designed to display Dexcom G5 continuous glucose monitoring, or CGM, sensor information directly on the pump Home Screen; and
10 10  * the t:flex Insulin Delivery System, or t:flex, for people with greater insulin needs.
... ... @@ -75,3 +75,5 @@
75 75  "With its robust product pipeline and increasing number of customer renewal opportunities, growth remains a top focus, but equally so is closely managing its expenses as the company leverage its existing infrastructure in 2018," said Leigh Vosseller, Senior Vice President and Chief Financial Officer. "The company believe its early investments have well-positioned the Company to achieve and support the scale necessary to reach its profitability goals, and the company expect to make meaningful progress in reducing its cash use in 2018."
76 76  
77 77  = References =
78 +
79 +{{putFootnotes/}}
This site is funded and maintained by Fintel.io